IACS Leadership
Executive Director, Strategic Alliances
Eric Devroe, Ph.D.
Eric Devroe, Ph.D., joins MD Anderson with extensive experience in launching and building new life science enterprises. At the Institute for Applied Cancer Science, he focuses broadly on business and strategy development as well as managing the institute’s finances. Prior to joining MD Anderson, he was the founding employee and vice president of Business and Strategy Development at Metamark Genetics, Inc., an oncology-focused molecular diagnostics company in Cambridge, MA. At Metamark he oversaw the development of the company’s intellectual property portfolio and completed twenty license and partnership agreements, including a $365 million alliance with Janssen Biotech, Inc. Prior to Metamark he was an associate at Flagship Ventures, a leading life science focused venture capital firm that manages over $900 million in capital. At Flagship he was a member of the founding team of Joule Unlimited, Inc., and an oncology-focused therapeutics company. Earlier in his career he held scientific and operating roles at Ambion, Asuragen, and Codon Devices. He received his Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University.
Institute Leadership
- Giulio Draetta, M.D., Ph.D. - Director
- Lynda Chin, M.D. - Scientific Director
- Carlo Toniatti, M.D., Ph.D. - Head of Research
- Philip Jones, Ph.D. - Head of Drug Discovery
- Eric Devroe, Ph.D. - Executive Director, Strategic Alliances
- Jannik Andersen, Ph.D. - Senior Associate Director, Drug Discovery Biology
- Joseph Marszalek, Ph.D. - Senior Associate Director, Target Validation
- Timothy Heffernan, Ph.D. - Associate Director, Target Discovery
- James Horner, B.S. - Associate Director, Mouse Cancer Models
- Ming-Kuei Jang, Ph.D., - Associate Director, Neurobiology
- Alexei Protopopov, Ph.D. - Associate Director, Oncogenomics
- Jianhua (John) Zhang, Ph.D. - Associate Director, Bioinformatics